In 2012, right before prescription drug-monitoring programs (PDMP) shut everything down, I was seeing 11 doctors every month—the same 11…
Walgreens, the nation’s second-largest pharmacy chain, will pay $300 million plus 4 percent interest to settle Department of Justice allegations…
Since the Food and Drug Administration approved over-the-counter (OTC) naloxone in 2023, pharmacies nationwide have stocked their shelves with the…
British Columbia’s provincial government has ended its take-home safe supply program for new participants, with an intention to transition existing…
The Department of Justice is accusing CVS Pharmacy Inc. of unlawfully filling opioid prescriptions that directly led to overdose deaths,…
[This article is excerpted from the book Policing Patients. You can read Filter’s interview with the author here.] Pharmacists’…
Policing Patients: Treatment and Surveillance on the Frontlines of the Opioid Crisis is a Swiss Army knife of a book.…
In bankruptcy court on July 9, OxyContin manufacturer Purdue Pharma secured an injunction to temporarily stave off lawsuits while it…
Walgreens is rolling out an over-the-counter (OTC) naloxone nasal spray, which it will sell alongside the OTC Narcan it already…
Amneal Pharmaceuticals, a New Jersey-based manufacturer known for generics, has agreed to settle the 900-plus lawsuits alleging it failed to…